New combo therapy aims to shrink tumors in hard-to-treat cancers
NCT ID NCT03915678
First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 31 times
Summary
This study is testing whether adding an immune-boosting drug (BDB001) and targeted radiation to the immunotherapy atezolizumab can help control or shrink tumors in people with advanced solid tumors, including pancreatic, lung, bladder, and breast cancers. About 247 adults with these cancers will receive the combination treatment. The main goal is to see how many patients have their disease controlled (shrink or stay stable) within 24 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
CHU Poitiers
RECRUITINGPoitiers, 86000, France
Contact Email: •••••@•••••
-
Centre Eugène Marquis
RECRUITINGRennes, 35042, France
Contact Email: •••••@•••••
-
Centre François Baclesse
RECRUITINGCaen, 14076, France
Contact Email: •••••@•••••
-
Centre Georges François Leclerc
RECRUITINGDijon, 21079, France
Contact
Contact
-
Centre Oscar Lambret
RECRUITINGLille, 59020, France
Contact
Contact
-
Chu Brest
RECRUITINGBrest, 29200, France
Contact
Contact
-
Hôpital La Timone
NOT_YET_RECRUITINGMarseille, 13005, France
Contact Email: •••••@•••••
-
IUCT Oncopôle
RECRUITINGToulouse, 31052, France
Contact
Contact
-
Institut Bergonié
RECRUITINGBordeaux, 33076, France
Contact Email: •••••@•••••
-
Institut Curie
NOT_YET_RECRUITINGParis, 75005, France
Contact
Contact
-
Institut Paoli Calmettes
RECRUITINGMarseille, 13273, France
Contact
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.